InsidersTradesSigma
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by LEE WILLIS C, Chief Executive Officer. Director active across 1 companies, notably Emmaus Life Sciences, Inc.. In total, 23 filings have been published. Total volume traded: €112k. The latest transaction was disclosed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations23 total
€8622,500 shares@ €0.34470.11% mcap0.8% of flow
Common stock, $0.001 par value
SEC:0001209191-22-033847:0·
Ideal exit: 21 Feb 2023 (T+270)
€2,8573,200 shares@ €0.89290.35% mcap2.5% of flow
Common stock, $0.001 par value
SEC:0001209191-22-024129:0·
Ideal exit: 30 Dec 2022 (T+270)
€628500 shares@ €1.25560.078% mcap0.6% of flow
Common stock, $0.001 par value
SEC:0001209191-22-013725:0·
Ideal exit: 19 Nov 2022 (T+270)
€681500 shares@ €1.36210.084% mcap1.3% of flow
Common stock, $0.001 par value
SEC:0001209191-22-001426·
Ideal exit: 30 Aug 2022 (T+270)
€681500 shares@ €1.36210.084% mcap0.6% of flow
Common stock, $0.001 par value
SEC:0001209191-22-001426:0·
Ideal exit: 30 Aug 2022 (T+270)
€31,46924,328 shares@ €1.29353.89% mcap58.4% of flow
Common stock, $0.001 par value
SEC:0001209191-21-067167·
Ideal exit: 23 Aug 2022 (T+270)
€31,46924,328 shares@ €1.29353.89% mcap28.0% of flow
Common stock, $0.001 par value
SEC:0001209191-21-067167:0·
Ideal exit: 23 Aug 2022 (T+270)
€4,1103,500 shares@ €1.17420.51% mcap7.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066920·
Ideal exit: 20 Aug 2022 (T+270)
€4,1103,500 shares@ €1.17420.51% mcap3.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066920:0·
Ideal exit: 20 Aug 2022 (T+270)
€1,7341,600 shares@ €1.08380.21% mcap3.2% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066428·
Ideal exit: 12 Aug 2022 (T+270)
€1,7341,600 shares@ €1.08380.21% mcap1.5% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066428:0·
Ideal exit: 12 Aug 2022 (T+270)
€2,5552,000 shares@ €1.27750.32% mcap4.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-056785·
Ideal exit: 12 Jun 2022 (T+270)
€2,5552,000 shares@ €1.27750.32% mcap2.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-056785:0·
Ideal exit: 12 Jun 2022 (T+270)
€2,8772,000 shares@ €1.43830.36% mcap5.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-055547·
Ideal exit: 5 Jun 2022 (T+270)
€2,8772,000 shares@ €1.43830.36% mcap2.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-055547:0·
Ideal exit: 5 Jun 2022 (T+270)
€3,0782,400 shares@ €1.28240.38% mcap5.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-053681·
Ideal exit: 22 May 2022 (T+270)
€3,0782,400 shares@ €1.28240.38% mcap2.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-053681:0·
Ideal exit: 22 May 2022 (T+270)
€3,3882,700 shares@ €1.25490.42% mcap6.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-036627·
Ideal exit: 20 Feb 2022 (T+270)
€3,3882,700 shares@ €1.25490.42% mcap3.0% of flow
Common stock, $0.001 par value
SEC:0001209191-21-036627:0·
Ideal exit: 20 Feb 2022 (T+270)
€1,4081,500 shares@ €0.9390.17% mcap2.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-032183·
Ideal exit: 4 Feb 2022 (T+270)
€1,4081,500 shares@ €0.9390.17% mcap1.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-032183:0·
Ideal exit: 4 Feb 2022 (T+270)
€2,6232,500 shares@ €1.04930.32% mcap4.9% of flow
Common stock, $0.001 par value
SEC:0001209191-21-030990·
Ideal exit: 30 Jan 2022 (T+270)
€2,6232,500 shares@ €1.04930.32% mcap2.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-030990:0·
Ideal exit: 30 Jan 2022 (T+270)
23 of 23 declarations
About LEE WILLIS C
Lee Willis C is an insider at Emmaus Life Sciences, Inc.
